| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Cyclin-C (SRB11 homolog) (hSRB11) |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | Synthesized peptide derived from human Cyclin C Polyclonal |
| Isotype | |
| Product Type | |
| Reactivity | |
| Storage |
Product Overview
Polyclonal Primary AntibodyAnti-Cyclin C rabbit pAb antibody (, -derived) validated for use in multiple research applications. Targets Cyclin C rabbit pAb in validated species samples.
Antibody Specifications
Scientific Background
The protein encoded by this gene is a member of the cyclin family of proteins. The encoded protein interacts with cyclin-dependent kinase 8 and induces the phophorylation of the carboxy-terminal domain of the large subunit of RNA polymerase II. The level of mRNAs for this gene peaks in the G1 phase of the cell cycle. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008],
Subcellular Location: Nucleus .
Safety & Handling
Related Products
Explore our complete catalog of antibodies, ELISA kits, and life science research reagents at BioHippo.
Store at -20°C for long-term storage. For short-term use (up to 4 weeks), store at 4°C. Avoid repeated freeze-thaw cycles. Centrifuge briefly before opening if condensation is visible.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.